{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T19:37:39Z","timestamp":1780342659655,"version":"3.54.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.ajog.2011.04.033","type":"journal-article","created":{"date-parts":[[2011,4,30]],"date-time":"2011-04-30T21:36:26Z","timestamp":1304199386000},"page":"S14-S17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"S","title":["The state of hormonal contraception today: benefits and risks of hormonal contraceptives: progestin-only contraceptives"],"prefix":"10.1016","volume":"205","author":[{"given":"Anne E.","family":"Burke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2011.04.033_bib1","series-title":"Plan B One Step [package insert]","year":"2009"},{"key":"10.1016\/j.ajog.2011.04.033_bib2","series-title":"Next Choice [package insert]","year":"2009"},{"key":"10.1016\/j.ajog.2011.04.033_bib3","series-title":"Ella [package insert]","year":"2010"},{"key":"10.1016\/j.ajog.2011.04.033_bib4","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.maturitas.2003.09.014","article-title":"Classification and pharmacology of progestins","volume":"46S1","author":"Schindler","year":"2003","journal-title":"Maturitas"},{"issue":"Suppl","key":"10.1016\/j.ajog.2011.04.033_bib5","first-page":"S1","article-title":"Progestin-only oral contraception: a comprehensive review","volume":"50","author":"McCann","year":"1994","journal-title":"Contraception"},{"issue":"Suppl","key":"10.1016\/j.ajog.2011.04.033_bib6","first-page":"S103","article-title":"Hormonal contraception: recent advances and controversies","volume":"90","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2011.04.033_bib7","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1055\/s-0030-1248137","article-title":"Injectable contraception","volume":"28","author":"Roy","year":"2010","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.ajog.2011.04.033_bib8","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0010-7824(82)90047-6","article-title":"A randomized, double-blinded study of two combined and two progestogen-only oral contraceptives","volume":"25","author":"Sheth","year":"1982","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2011.04.033_bib9","series-title":"Contraceptive technology","article-title":"Contraceptive efficacy","author":"Trussell","year":"2007"},{"key":"10.1016\/j.ajog.2011.04.033_bib10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.contraception.2004.03.009","article-title":"Contraceptive failure in the United States","volume":"70","author":"Trussell","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2011.04.033_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007541.pub2","article-title":"Progestin-only pills for contraception","volume":"1","author":"Grimes","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2011.04.033_bib12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.contraception.2010.02.002","article-title":"Progestogen-only contraceptive use among breastfeeding women: a systematic review","volume":"82","author":"Kapp","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2011.04.033_bib13","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.contraception.2009.02.008","article-title":"Menstrual pattern changes from levonorgestrel subdermal implants and DMPA: systematic review and evidence-based comparisons","volume":"80","author":"Hubacher","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2011.04.033_bib14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(82)90320-8","article-title":"Medroxyprogesterone acetate and homozygous sickle-cell disease","volume":"2","author":"De Ceulaer","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2011.04.033_bib15","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1212\/WNL.34.9.1255","article-title":"Treatment of seizures with medroxyprogesterone acetate: preliminary report","volume":"34","author":"Mattson","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.ajog.2011.04.033_bib16","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.fertnstert.2005.07.1315","article-title":"Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain","volume":"85","author":"Schlaff","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2011.04.033_bib17","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1055\/s-2001-18641","article-title":"Current options for injectable contraception in the United States","volume":"19","author":"Kaunitz","year":"2001","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.ajog.2011.04.033_bib18","series-title":"Implanon [package insert]","year":"2009"},{"key":"10.1016\/j.ajog.2011.04.033_bib19","doi-asserted-by":"crossref","first-page":"494","DOI":"10.2105\/AJPH.85.4.494","article-title":"The economic value of contraception: a comparison of 15 methods","volume":"85","author":"Trussell","year":"1995","journal-title":"Am J Public Health"},{"key":"10.1016\/j.ajog.2011.04.033_bib20","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.contraception.2004.11.007","article-title":"Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel","volume":"71","author":"Funk","year":"2005","journal-title":"Contraception"},{"issue":"Suppl","key":"10.1016\/j.ajog.2011.04.033_bib21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/13625180801959931","article-title":"The effects of Implanon on menstrual bleeding patterns","volume":"13","author":"Mansour","year":"2008","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.ajog.2011.04.033_bib22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1783\/0000000052972799","article-title":"Treatment of pelvic endometriosis with etonogestrel subdermal implant (Implanon)","volume":"31","author":"Yisa","year":"2005","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.ajog.2011.04.033_bib23","series-title":"Mirena [package insert]","year":"2009"},{"key":"10.1016\/j.ajog.2011.04.033_bib24","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0010-7824(94)90109-0","article-title":"Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial","volume":"49","author":"Andersson","year":"1994","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2011.04.033_bib25","first-page":"716","article-title":"Health effects of long-term use of the intrauterine levonorgestrel-releasing system: a follow-up study over 12 years of continuous use","volume":"78","author":"R\u00f6nnerdag","year":"1999","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2011.04.033_bib26","first-page":"1","article-title":"US medical eligibility criteria for contraceptive use, 2010","volume":"59","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.ajog.2011.04.033_bib28","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.contraception.2008.06.016","article-title":"Assessment of Implanon insertion and removal","volume":"78","author":"Levine","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2011.04.033_bib29","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1093\/oxfordjournals.humrep.a135819","article-title":"Performance of copper intrauterine devices when inserted after an expulsion","volume":"10","author":"Bahamondes","year":"1995","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2011.04.033_bib30","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.contraception.2005.08.007","article-title":"Does insertion and use of an intrauterine device increase the risk of pelvic inflammatory disease among women with sexually transmitted infection?","volume":"73","author":"Mohllajee","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2011.04.033_bib31","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1055\/s-0030-1248135","article-title":"Contraceptive implants","volume":"28","author":"McDonald-Mosley","year":"2010","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.ajog.2011.04.033_bib32","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.contraception.2008.02.001","article-title":"Effect of an emergency contraceptive pill intervention on pregnancy risk behavior","volume":"77","author":"Raymond","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2011.04.033_bib33","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.contraception.2006.03.008","article-title":"Changes in bleeding patterns with depot medroxyprogesterone acetate subcutaneous injection 104 mg","volume":"74","author":"Arias","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2011.04.033_bib34","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1097\/AOG.0b013e3181b76bea","article-title":"Effect of injectable and oral contraceptives on lipids","volume":"114","author":"Berenson","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2011.04.033_bib35","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0010-7824(93)90090-T","article-title":"A multicenter comparative study of serum lipids and apolipoproteins in long-term users of DMPA and a control group of IUD users","volume":"47","author":"Kongsayreepong","year":"1993","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2011.04.033_bib36","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.contraception.2009.07.007","article-title":"Prospective study of weight change in new adolescent users of DMPA, NET-EN, COCs, nonusers and discontinuers of hormonal contraception","volume":"81","author":"Beksinska","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2011.04.033_bib37","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.contraception.2009.07.008","article-title":"Variations in body mass index of users of depot-medroxyprogesterone acetate as a contraceptive","volume":"81","author":"Pantoja","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2011.04.033_bib38","series-title":"Depo-Provera [package insert]","year":"2010"},{"key":"10.1016\/j.ajog.2011.04.033_bib39","doi-asserted-by":"crossref","first-page":"329.e1","DOI":"10.1016\/j.ajog.2008.12.052","article-title":"Changes in weight, total fat, percent body fat, and central-to-peripheral fat ratio associated with injectable and oral contraceptive use","volume":"200","author":"Berenson","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2011.04.033_bib40","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.contraception.2009.04.006","article-title":"Progestogen-only contraceptive use in obese women","volume":"80","author":"Curtis","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2011.04.033_bib41","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1055\/s-0030-1248141","article-title":"Obesity and contraception: emerging issues","volume":"28","author":"Murthy","year":"2010","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.ajog.2011.04.033_bib42","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.contraception.2009.02.005","article-title":"Subcutaneous DMPA vs intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density","volume":"80","author":"Kaunitz","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2011.04.033_bib43","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/archpedi.159.2.139","article-title":"Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception","volume":"159","author":"Scholes","year":"2005","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.ajog.2011.04.033_bib44","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/00001648-200209000-00015","article-title":"Injectable hormone contraception and bone density: results from a prospective study","volume":"13","author":"Scholes","year":"2002","journal-title":"Epidemiology"},{"key":"10.1016\/j.ajog.2011.04.033_bib45","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.contraception.2005.12.010","article-title":"Progestogen-only contraception and bone mineral density: a systematic review","volume":"73","author":"Curtis","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2011.04.033_bib46","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/j.fertnstert.2007.10.070","article-title":"Bone mineral density in adolescent females using injectable or oral contraceptives: a 24 month prospective study","volume":"90","author":"Cromer","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2011.04.033_bib47","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.contraception.2006.03.010","article-title":"Bone mineral density in women aged 25-35 years receiving depot medroxyprogesterone acetate: recovery following discontinuation","volume":"74","author":"Kaunitz","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2011.04.033_bib48","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.contraception.2009.11.003","article-title":"Recovery of bone mineral density in adolescents following the use of depot edroxyprogesterone acetate contraceptive injections","volume":"81","author":"Harel","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2011.04.033_bib49","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.contraception.2005.05.011","article-title":"Depo-Provera's black box: time to reconsider","volume":"72","author":"Kaunitz","year":"2005","journal-title":"Contraception"},{"issue":"Suppl","key":"10.1016\/j.ajog.2011.04.033_bib50","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/13625180801960012","article-title":"Tolerability and clinical safety of Implanon","volume":"13","author":"Blumenthal","year":"2008","journal-title":"Eur J Contracep Reprod Health Care"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937811005205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937811005205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:32:22Z","timestamp":1762079542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937811005205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0002937811005205"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2011.04.033","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The state of hormonal contraception today: benefits and risks of hormonal contraceptives: progestin-only contraceptives","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2011.04.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}